157 related articles for article (PubMed ID: 7654701)
1. Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE.
Liu J; Lester P; Builder S; Shire SJ
Biochemistry; 1995 Aug; 34(33):10474-82. PubMed ID: 7654701
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys.
Fox JA; Hotaling TE; Struble C; Ruppel J; Bates DJ; Schoenhoff MB
J Pharmacol Exp Ther; 1996 Nov; 279(2):1000-8. PubMed ID: 8930210
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human IgE with soluble forms of IgE high affinity receptors.
Liu J; Ruppel J; Shire SJ
Pharm Res; 1997 Oct; 14(10):1388-93. PubMed ID: 9358551
[TBL] [Abstract][Full Text] [Related]
5. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis.
Casale TB; Bernstein IL; Busse WW; LaForce CF; Tinkelman DG; Stoltz RR; Dockhorn RJ; Reimann J; Su JQ; Fick RB; Adelman DC
J Allergy Clin Immunol; 1997 Jul; 100(1):110-21. PubMed ID: 9257795
[TBL] [Abstract][Full Text] [Related]
6. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.
Milgrom H; Fick RB; Su JQ; Reimann JD; Bush RK; Watrous ML; Metzger WJ
N Engl J Med; 1999 Dec; 341(26):1966-73. PubMed ID: 10607813
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of allergic diseases with monoclonal anti-IgE antibody].
Morita Y
Nihon Rinsho; 2001 Oct; 59(10):2019-22. PubMed ID: 11676148
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibody therapy for allergic asthma].
Nishikawa M; Matsuse T
Nihon Rinsho; 2002 Mar; 60(3):591-7. PubMed ID: 11904978
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-IgE antibodies on Fc epsilonRI-bound IgE.
Rudolf MP; Furukawa K; Miescher S; Vogel M; Kricek F; Stadler BM
J Immunol; 1996 Dec; 157(12):5646-52. PubMed ID: 8955217
[TBL] [Abstract][Full Text] [Related]
10. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
[TBL] [Abstract][Full Text] [Related]
11. Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization.
Mitropoulou AN; Ceska T; Heads JT; Beavil AJ; Henry AJ; McDonnell JM; Sutton BJ; Davies AM
Acta Crystallogr F Struct Biol Commun; 2020 Mar; 76(Pt 3):116-129. PubMed ID: 32133997
[TBL] [Abstract][Full Text] [Related]
12. Anti-IgE as novel therapy for the treatment of asthma.
Fick RB
Curr Opin Pulm Med; 1999 Jan; 5(1):76-80. PubMed ID: 10813254
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibody.
Rudolf MP; Zuercher AW; Nechansky A; Ruf C; Vogel M; Miescher SM; Stadler BM; Kricek F
J Immunol; 2000 Jul; 165(2):813-9. PubMed ID: 10878355
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of allergic reactions with antibodies to IgE.
Shields RL; Whether WR; Zioncheck K; O'Connell L; Fendly B; Presta LG; Thomas D; Saban R; Jardieu P
Int Arch Allergy Immunol; 1995; 107(1-3):308-12. PubMed ID: 7613156
[TBL] [Abstract][Full Text] [Related]
15. Structure of the omalizumab Fab.
Jensen RK; Plum M; Tjerrild L; Jakob T; Spillner E; Andersen GR
Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):419-26. PubMed ID: 25849503
[TBL] [Abstract][Full Text] [Related]
16. Epitope-specific antibody response to IgE by mimotope immunization.
Rudolf MP; Vogel M; Kricek F; Ruf C; Zürcher AW; Reuschel R; Auer M; Miescher S; Stadler BM
J Immunol; 1998 Apr; 160(7):3315-21. PubMed ID: 9531289
[TBL] [Abstract][Full Text] [Related]
17. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody.
Chen JB; Ramadani F; Pang MOY; Beavil RL; Holdom MD; Mitropoulou AN; Beavil AJ; Gould HJ; Chang TW; Sutton BJ; McDonnell JM; Davies AM
Sci Rep; 2018 Aug; 8(1):11548. PubMed ID: 30069035
[TBL] [Abstract][Full Text] [Related]
19. Humanization of an antibody directed against IgE.
Presta LG; Lahr SJ; Shields RL; Porter JP; Gorman CM; Fendly BM; Jardieu PM
J Immunol; 1993 Sep; 151(5):2623-32. PubMed ID: 8360482
[TBL] [Abstract][Full Text] [Related]
20. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model.
Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW
Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
